Exelixis, Inc.
Exelixis, Inc.
Back to Directory   


 

Exelixis' Cabozantinib Shows Encouraging Clinical Activity in Patients With Metastatic Breast Cancer

 
  Message From The Company
This information is not currently provided by Exelixis, Inc..
  Our Most Recent Webcast
SYMBOL EVENT TITLE  LISTEN DATE TIME (ET)
EXEL Q1 2013 Exelixis, Inc. Earnings Conference Call 7-May-13 5:00 PM
  Our Most Recent Annual Report
SYMBOL REPORT TITLE  DATE FORMAT
EXEL 2010 Annual Report (pdf) 19-Apr-2011